NO20052859L - Fremgangsmate for fremstilling av resperidon og intermediater derav - Google Patents

Fremgangsmate for fremstilling av resperidon og intermediater derav

Info

Publication number
NO20052859L
NO20052859L NO20052859A NO20052859A NO20052859L NO 20052859 L NO20052859 L NO 20052859L NO 20052859 A NO20052859 A NO 20052859A NO 20052859 A NO20052859 A NO 20052859A NO 20052859 L NO20052859 L NO 20052859L
Authority
NO
Norway
Prior art keywords
resperidone
intermediates
preparation
enriched
isomeroxime
Prior art date
Application number
NO20052859A
Other languages
English (en)
Norwegian (no)
Other versions
NO20052859D0 (no
Inventor
Pavel Slanina
Jiri Bartl
Original Assignee
Synthon Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthon Bv filed Critical Synthon Bv
Publication of NO20052859D0 publication Critical patent/NO20052859D0/no
Publication of NO20052859L publication Critical patent/NO20052859L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56—Nitrogen atoms
    • C07D211/58—Nitrogen atoms attached in position 4

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20052859A 2002-11-13 2005-06-13 Fremgangsmate for fremstilling av resperidon og intermediater derav NO20052859L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US42572702P 2002-11-13 2002-11-13
PCT/EP2003/012504 WO2004043923A1 (fr) 2002-11-13 2003-11-07 Procede de fabrication de la risperidone et des intermediaires associes

Publications (2)

Publication Number Publication Date
NO20052859D0 NO20052859D0 (no) 2005-06-13
NO20052859L true NO20052859L (no) 2005-08-05

Family

ID=32313043

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20052859A NO20052859L (no) 2002-11-13 2005-06-13 Fremgangsmate for fremstilling av resperidon og intermediater derav

Country Status (9)

Country Link
US (2) US7405298B2 (fr)
EP (1) EP1560814A1 (fr)
CN (1) CN100390146C (fr)
AR (1) AR041954A1 (fr)
AU (1) AU2003288017A1 (fr)
HR (1) HRP20050424A2 (fr)
NO (1) NO20052859L (fr)
WO (1) WO2004043923A1 (fr)
ZA (1) ZA200503698B (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA200603113B (en) * 2003-09-26 2007-08-29 Jubilant Organosys Ltd Process for the preparation of risperidone
WO2009077551A1 (fr) * 2007-12-18 2009-06-25 Janssen Pharmaceutica Nv Procédé de préparation de la rispéridone
US8772345B2 (en) 2011-08-03 2014-07-08 Southwest Research Institute Oximes for treatment of peripheral and central nervous system exposure to acetyl cholinesterase inhibitors
US8653108B1 (en) 2011-08-03 2014-02-18 Southwest Research Institute Oximes for treatment of peripheral and central nervous system exposure to acetyl cholinesterase inhibitors
US9162983B2 (en) 2013-05-22 2015-10-20 Southwest Research Institute Reactivators of organophosphorous inhibited acetylcholinesterase
CN104557918A (zh) * 2014-12-12 2015-04-29 瑞阳制药有限公司 苯并异恶唑类抗精神病药利培酮的制备方法
CN107422055A (zh) * 2017-07-27 2017-12-01 天津药物研究院药业有限责任公司 一种利培酮原料或制剂中杂质的检测方法
CN108445101B (zh) * 2018-03-16 2021-01-01 安徽新世纪药业有限公司 一种利培酮口服溶液有关物质的检测方法
CN109438443A (zh) * 2018-12-24 2019-03-08 浙江工业大学上虞研究院有限公司 利培酮的制备方法
CN111777601B (zh) * 2020-05-23 2021-07-16 白银京宇新药业有限公司 一种6-氟-3-(4-哌啶基)-1，2苯并异噁唑盐酸盐的制备方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3946022A (en) * 1974-03-04 1976-03-23 Richardson-Merrell Inc. Piperidine derivatives
US4335127A (en) 1979-01-08 1982-06-15 Janssen Pharmaceutica, N.V. Piperidinylalkyl quinazoline compounds, composition and method of use
US4342870A (en) 1980-03-28 1982-08-03 Janssen Pharmaceutica N.V. Novel 3-(1-piperidinylalkyl)-4H-pyrido[1,2-a]pyrimidin-4-one derivatives
US4408054A (en) * 1981-11-12 1983-10-04 Hoechst-Roussel Pharmaceuticals Inc. Oximes of 4-benzoyl-piperidines
US4804663A (en) 1985-03-27 1989-02-14 Janssen Pharmaceutica N.V. 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles
CA2000786C (fr) 1988-11-07 1999-01-26 Cornelus G. M. Janssen 3-piperidinyl-1,2-benzisoxazoles
GB9008850D0 (en) * 1990-04-19 1990-06-13 Janssen Pharmaceutica Nv Novel 2,9-disubstituted-4h-pyridol(1,2-a)pyrimidin-4-ones
ES2050069B1 (es) * 1992-07-10 1994-12-16 Vita Invest Sa Procedimiento para la obtencion de 3-(2-(4-(6-fluoro-1,2-benzisoxazol-3-il)piperidino)etil)-2-metil-6,7,8,9-tetrahidro-4h-pirido(1,2-a) pirimidin-4-ona.
ES2074966B1 (es) 1994-02-11 1996-06-16 Vita Invest Sa Procedimiento para la obtencion de 3-(2-(4-(6-fluoro-benzo(d)isoxazol-3-il)piperidin-1-il)-etil)-2-metil-6,7,8,9-tetrahidro-4h-pirido-(1,2-a)pirimidin-4-ona.
CZ295402B6 (cs) 2000-05-05 2005-08-17 Rpg Life Sciences Limited Způsob přípravy antipsychotického 3-[2-[4-(6-fluor-1,2-benzizoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2,-a]pyrimidin-4-onu
US20020115672A1 (en) 2000-08-08 2002-08-22 Barnaba Krochmal Preparation of risperidone
EP1982980A1 (fr) 2000-08-14 2008-10-22 Teva Pharmaceutical Industries Ltd. Forme cristalline de la rispéridone
HU227118B1 (en) 2001-11-13 2010-07-28 Egis Gyogyszergyar Nyilvanosan Process for the preparation of 3-{2-[4-(6-fluoro-1,2-benzizoxazol-3-yl)-1-piperidinyl]-ethyl}-6,7,8,9-tetrahydro-2-methyl-4h-pyrido[1,2-a]pyrimidin-4-one
MXPA06007654A (es) * 2003-12-31 2006-09-04 Warner Lambert Co Derivados de piperidina n-sustituidos.

Also Published As

Publication number Publication date
HRP20050424A2 (en) 2006-08-31
CN100390146C (zh) 2008-05-28
WO2004043923A1 (fr) 2004-05-27
US7405298B2 (en) 2008-07-29
AR041954A1 (es) 2005-06-01
AU2003288017A1 (en) 2004-06-03
NO20052859D0 (no) 2005-06-13
EP1560814A1 (fr) 2005-08-10
US20080262227A1 (en) 2008-10-23
CN1720228A (zh) 2006-01-11
ZA200503698B (en) 2006-08-30
US20040097523A1 (en) 2004-05-20

Similar Documents

Publication Publication Date Title
NO20052859L (no) Fremgangsmate for fremstilling av resperidon og intermediater derav
RU2335493C2 (ru) Производные хинолина в качестве ингибиторов фосфодиэстеразы
NO20083411L (no) Indaneddiksyrederivater og deres anvendelse som farmasoytiske midler, intermediater og fremgangsmater for fremstilling
NO20055977L (no) Nye benzimidazolderivater
CO5560083A1 (es) Formas polimorficas de rifaximina, procesos para su produccion y uso de las mismas en preparaciones
NO20090328L (no) Nye forbindelser 385
CL2004000293A1 (es) Compuestos derivados de dihidrofenantridin-sulfonamidas sustituidas, sus sales; procedimiento de preparacion; composicion farmaceutica; compuestos intermediarios; y su uso en el tratamiento de la diabetes tipo ii, alzheimer, demencia senil, asma, col
DE60315674D1 (de) Neue imidazopyridine und ihre verwendung
NO20055219L (no) Nye forbindelser
NO20033181L (no) Substituerte alkylaminderivater og fremgangsmåter for anvendelse
NO20082000L (no) Pyrimidinamidforbindelser som PGDS-inhibitorer
NO20091560L (no) Biaryleterureaforbindelser
ATE284860T1 (de) Neue verwendung von phenylheteroalkylamin- derivaten
DK1427297T3 (da) Appetitnedsættende procyanidin-holdigt præparat til pattedyr
EA200800370A1 (ru) Новая фармацевтическая лекарственная форма ингибитора фермента циклооксигеназы с модифицированным высвобождением
NZ545631A (en) Fexofenadine polymorphs and processes of preparing the same
HRP20030141A2 (en) Phenoxybenzylamine derivatives as selective serotonin re-uptake inhibitors
ATE303384T1 (de) 1-biaryl-1,8-naphthyridin-4-one als phosphodieseterase-inhibitoren
SI1572699T1 (sl) Kristalne soli cefdinira
PE20000477A1 (es) Procedimiento para la preparacion de (s,s)-bencil-2,8-diazabiciclo[4.3.0)nonano
EP4185566A1 (fr) Composés d'isoquinoléine et leur utilisation dans le traitement d'un déséquilibre du ahr
NO20082297L (no) Piperazinderivater som er anvendelige som CCR5-antagonister
HRP20080318T3 (en) Benzothiazole derivatives and use thereof in the treatment of diseases related to the adenosine a2a receptor
NO330989B1 (no) Nye piperazinderivater, fremgangsmater for fremstilling av slike og deres anvendelse som syntesemellomprodukter.
NO20062307L (no) Spirofuropyridinarylderivater

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application